Shelly graduated from Shenyang University of Chemical Technology with a major in Polymer Chemistry. She has over 15 years of experiences in commercial and clinical supply chain management in multinational pharmaceutical companies (MNCs) including Covance, Sanofi and Amgen, during which she supported the establishment of Asia-Pacific R&D centers, as well as multiple projects involving the launch, import and localization switching of products in China. At the meanwhile, she has also participated in the supply for Phase I-III clinical trials in China, the United States and the Asia-Pacific region in therapeutic areas such as oncology, metabolism and autoimmune diseases.
Shelly joined Eli Lilly China in 2023 and currently serves as the Head of Clinical and QC Supply Chain. She continues to promote China’s synchronous R&D strategy, strengthen the connection between local and global supply processes, ensure the supply of registered drugs, build team capabilities, and actively participate in the construction of external ecosystems related to clinical supply.
Shelly毕业于沈阳化工大学高分子化学专业，拥有超过15年在跨国制药企业（MNC）从事商业及临床供应链管理的经验。曾任职于科文斯、赛诺菲和安进等跨国药企，期间支持亚太研发中心的建立以及多个产品的中国上市、进口与本地化转产项目，并参与肿瘤、代谢、自身免疫等治疗领域的中美及亚太区域I~III期临床试验供应。Shelly于2023年加入礼来中国，现任临床及QC供应链负责人，持续推动中国同步研发策略，强化本地与全球供应流程衔接、注册用药保障及团队能力建设，并积极参与临床供应相关的外部生态系统建设。